[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617896":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":37,"centralContacts":41,"locations":47,"responsibleParty":65,"collaborators":67,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":28,"enrollmentInfo":80,"targetDuration":28,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":50,"whyStopped":28,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Wake Forest University Health Sciences","OTHER",[8,13,18],{"label":9,"type":6,"description":10,"interventionNames":11},"Standard of care","Standard of care radiation therapy for prostate, lung, breast cancer without using the VR headset",[12],"Other: standard of care",{"label":14,"type":6,"description":15,"interventionNames":16},"Virtual Reality intervention","Participants will wear the VR headset (Quest 2 by Meta) during radiation therapy",[12,17],"Other: Virtual Reality Intervention",{"label":19,"type":6,"description":20,"interventionNames":21},"Radiation Therapists","Providers that administer the VR intervention",[22],"Other: Radiation Therapist Survey",[24,29,33],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"standard of care","Radiation therapy for prostate cancer, breast cancer, lung cancer, or head and neck cancer.",[9,14],null,{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":28},"Virtual Reality Intervention","Participants will wear the VR headset (Meta Quest 2) during standard of care radiation therapy",[14],{"type":6,"name":34,"description":35,"armGroupLabels":36,"otherNames":28},"Radiation Therapist Survey","Radiation therapists will be asked about their experiences and proficiency with using the VR device.",[19],[38],{"name":39,"affiliation":5,"role":40},"Stephanie Parker, MS","PRINCIPAL_INVESTIGATOR",[42],{"name":43,"role":44,"phone":45,"phoneExt":28,"email":46},"Sheri Whittington","CONTACT","336-878-6107","Sheri.Whittington@Advocatehealth.org",[48],{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Atrium Health Wake Forest Baptist Hayworth Cancer Center","RECRUITING","High Point","North Carolina","27262","United States","US",{"type":57,"coordinates":58},"Point",[59,60],-80.00532,35.95569,{"lat":60,"lon":59},[63,64],{"name":43,"role":44,"phone":45,"phoneExt":28,"email":46},{"name":39,"role":40,"phone":28,"phoneExt":28,"email":28},{"type":66,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR",[68],{"name":69,"class":6},"Atrium Health Wake Forest Baptist","100617896","effectiveness-of-virtual-reality-vr-in-the-management-of-anxiety-for-patients-undergoing-radiotherapy-100617896",false,"NCT07324577","Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy","Effectiveness of Virtual Reality in the Management of Anxiety for Patients Undergoing Radiotherapy","RELAX","Patients:\n\nInclusion Criteria:\n\n* Participants planned for radiation therapy for 15 or more treatments with non-neutron generating energies (10 MV or less) per study PI for prostate, breast, lung, or head and neck cancer. Neutrons have the potential to damage the VR headset device and are generated for energies above 10 MV.\n* Age 18 years or older at the time of consent.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 at the time of enrollment.\n* Ability to understand and the willingness to sign an IRB-approved informed consent document directly.\n\nExclusion Criteria:\n\n* Previous radiation therapy\n* VR device is determined to impede the radiation dosage during the VR device simulation and treatment planning\n* Participants with primary brain tumors, brain metastases, and cancer involving the sinuses, orbits, nose, or ears, are excluded from this clinical trial because the VR device may obstruct the area being treated\n* Participants with uncontrolled inter-current illness including but not limited to psychiatric illness\u002Fsocial situations that would limit compliance with study requirements per treating radiation oncologist.\n* Participants with known epilepsy, significant motion sickness, severe uncorrected visual impairment, severe uncorrected hearing impairment, or seizures, per participant report.\n* Participants with skin defects, infections, or open wounds in the area where the VR device is applied (face or scalp) or in the eyes per treating radiation oncologist.\n* Participants with pacemakers, internal defibrillators, hearing aid, or other implanted medical device. The Meta Quest device contains magnets and components that emit magnetic\u002Felectromagnetic fields which could affect the operation of nearby electronics and medical devices.\n\nRadiation Therapists:\n\nInclusion Criteria:\n\n* Agreement to participate after reviewing the information sheet\n* Radiation therapist at AHWFBCCC High Point who has treated at least one participant who enrolled on to the study and used the VR device.","ALL","18 Years",{"count":81,"type":82},54,"ESTIMATED","INTERVENTIONAL",[85],"NA","The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer.",[88,89],"Radiation Therapy","Virtual Reality",[89,91,88],"Cancer","2026-05-21",{"date":94,"type":95},"2026-05-22","ACTUAL",{"date":97,"type":95},"2026-05-07",{"date":99,"type":82},"2029-02-01",{"name":5,"class":6},1]